Literature DB >> 22015702

A mechanism of carbapenem resistance due to a new insertion element (ISPa133) in Pseudomonas aeruginosa.

Lidia Ruiz-Martínez1, Lidia López-Jiménez, Valeria d'Ostuni, Ester Fusté, Teresa Vinuesa, Miguel Viñas.   

Abstract

This study explored the evolutionary mechanism by which the clinical isolate PA110514 yields the imipenemresistant derivative PA116136. Both isolates were examined by PFGE and SDS-PAGE, which led to the identification of a new insertion sequence, ISPa133. This element was shown to have distinct chromosomal locations in each of the original isolates that appeared to explain the differences in imipenem susceptibilty. In strain PA110514, ISPa133 is located 56 nucleotides upstream of the translational start codon, which has no effect on expression of the porin OprD. However, in strain PA116136 ISPa133 it is located in front of nucleotide 696 and, by interrupting the coding region, causes a loss of OprD expression, thus conferring imipenem resistance. In vitro experiments mimicking the natural conditions of selective pressure yielded imipenem-resistant strains in which ISPa133 similarly interrupted oprD. A mechanism is proposed whereby ISPa133 acts as a mobile switch, with its position in oprD depending on the degree of selective pressure exerted by imipenem.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015702     DOI: 10.2436/20.1501.01.135

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  10 in total

1.  Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.

Authors:  Alba Bellés; Jessica Bueno; Beatriz Rojo-Bezares; Carmen Torres; F Javier Castillo; Yolanda Sáenz; Cristina Seral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-06       Impact factor: 3.267

2.  First detection of insertion sequence element ISPa1328 in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from an idiopathic pulmonary fibrosis patient in Marseille, France.

Authors:  C Al-Bayssari; C Valentini; C Gomez; M Reynaud-Gaubert; J-M Rolain
Journal:  New Microbes New Infect       Date:  2015-05-14

3.  Emergence of carbapenem resistance due to the novel insertion sequence ISPa8 in Pseudomonas aeruginosa.

Authors:  Randal C Fowler; Nancy D Hanson
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

4.  Antimicrobial resistance and virulence of Pseudomonas spp. among healthy animals: concern about exolysin ExlA detection.

Authors:  Lidia Ruiz-Roldán; Beatriz Rojo-Bezares; María de Toro; María López; Paula Toledano; Carmen Lozano; Gabriela Chichón; Lydia Alvarez-Erviti; Carmen Torres; Yolanda Sáenz
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

5.  Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.

Authors:  Carmen Lozano; José Manuel Azcona-Gutiérrez; Françoise Van Bambeke; Yolanda Sáenz
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

6.  Spread of Carbapenem Resistance by Transposition and Conjugation Among Pseudomonas aeruginosa.

Authors:  Anneke van der Zee; W Bart Kraak; Arjan Burggraaf; Wil H F Goessens; Walter Pirovano; Jacobus M Ossewaarde; Jan Tommassen
Journal:  Front Microbiol       Date:  2018-09-05       Impact factor: 5.640

Review 7.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

8.  Pseudomonas aeruginosa Isolates from Spanish Children: Occurrence in Faecal Samples, Antimicrobial Resistance, Virulence, and Molecular Typing.

Authors:  Lidia Ruiz-Roldán; Alba Bellés; Jessica Bueno; José Manuel Azcona-Gutiérrez; Beatriz Rojo-Bezares; Carmen Torres; F Javier Castillo; Yolanda Sáenz; Cristina Seral
Journal:  Biomed Res Int       Date:  2018-06-11       Impact factor: 3.411

9.  Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems.

Authors:  Héctor Rudilla; Ester Fusté; Yolanda Cajal; Francesc Rabanal; Teresa Vinuesa; Miguel Viñas
Journal:  Molecules       Date:  2016-09-12       Impact factor: 4.411

10.  Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital.

Authors:  Alma López-García; Rosa Del Carmen Rocha-Gracia; Elena Bello-López; Claudia Juárez-Zelocualtecalt; Yolanda Sáenz; Miguel Castañeda-Lucio; Liliana López-Pliego; María Cristina González-Vázquez; Carmen Torres; Teolincacihuatl Ayala-Nuñez; Guadalupe Jiménez-Flores; Margarita María de la Paz Arenas-Hernández; Patricia Lozano-Zarain
Journal:  Infect Drug Resist       Date:  2018-09-20       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.